Condition: NAFLD - Nonalcoholic Fatty Liver Disease · Diabetes · Obesity · Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
The main aim of the study is to set up an observational cohort with NAFLD (Non-alcoholic fatty liver disease) at different stage of disease (from simple steatosis to cirrhosis and/or HCC-Hepatocellular carcinoma) and for comparative purpose a cohort of subjects with diabetes and/or obesity and/or other risk factors (i.e. psoriasis, IBD (inflammatory bowel disease), dyslipidemia) without NAFLD in order to have a clinical phenotypical characterization and the collection of biological specimens. We will collect clinical data, biological samples and imaging results in order to perform future cross-sectional studies and/or longitudinal studies for elucidating pathways of the disease and develop and validate biomarkers for diagnosis, prognosis and monitoring liver disease and comorbidities in order to contribute to precision medicine in this field.
This description comes directly from the study's public registry record.
LUCA MIELE, MD, PhD · +390631051 · luca.miele@policlinicogemelli.it; luca.miele@unicatt.it
Always discuss trial participation with your own doctor first.
| Catholic University of Rome, Fondazione Policlinico Gemelli IRCCS | Roma, Rome/lazio/italy, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04371042